CardioRenal
Platform enables doctors to optimise patient treatment through remote monitoring of key blood biomarkers.
CardioRenal has raised €3.3M across 1 funding round from 1 investor, most recently a round in Apr 2022. Based in Grenoble, France; active in Healthtech. Data as of 28 Oct 2026.
Grenoble, Francewww.cardio-renal.com ↗
Total raised
€3.3M
€3,300,000
Funding rounds
1
Investors
1
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearCardioRenal — funding by year — interactive chart.
Data table
| CardioRenal — funding by year | |
|---|---|
| 2022 | €3.3M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-04 | Other | €3.3M | Business Angels | View deal → |
Investors
1Business Angels
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData